NAD+ IV Protocol vs Oral NMN
NAD+ IV delivers direct, high-magnitude tissue replenishment on a periodic cadence. Oral NMN raises NAD+ precursor levels daily at lower magnitude with better convenience. The two are complementary in modern longevity protocols.
NAD+ IV is the provider-reviewed pathway when high-magnitude periodic replenishment is the goal.
Explore pathwayOral NMN is appropriate as daily background support and can complement periodic IV protocols.
Educational. Final pathway selection is provider-reviewed via synchronous video consultation against your biomarkers, history, and goals.
Frequently asked
Are they redundant?
No — pulsed IV and continuous oral occupy different roles.
Which has more evidence?
IV evidence is stronger for tissue NAD+ restoration; oral NMN evidence is emerging.
Take the optimization assessment.
The adaptive assessment maps your symptoms, history, and goals to candidate pathways — and routes you into provider review.
Begin assessment